Curo Remedies Private Limited - Company Profile

It is a manufacturing private limited company based in Thane, Maharashtra, India, established in 2012.
2012 Thane, Maharashtra, India Struck Off
Last Updated:
Access Report
About Curo Remedies Private Limited

Curo Remedies Private Limited, a struck off private limited company, was established on 02 November 2012 in Thane, Maharashtra, India. Engaging in other within the manufacturing sector, it holds CIN: U36900MH2012PTC237471. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Nilesh Phadnis (Director), Prakash Vasant Phadnis (Director), Aditi Nilesh Phadnis (Director). It is based at 402, Anand, Kores Towers Pokhran Road No.1, Vartak Nagar, Thane, Maharashtra, 400606.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U36900MH2012PTC237471

  • Registration Number

    237471

  • Incorporation Date

    02 November 2012

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 13 Year, 7 Months
Company report

Curo Remedies Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Curo Remedies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Curo Remedies Private Limited?
Current Directors
Name Designation Appointment Date Status
Nilesh Phadnis Director 02 Nov 2012 Current
Prakash Vasant Phadnis Director 02 Nov 2012 Current
Aditi Nilesh Phadnis Director 02 Nov 2012 Current
Sandhya Prakash Phadnis Director 02 Nov 2012 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Curo Remedies.

Enhance accessibility to Curo Remedies's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Curo Remedies revenue growth over time
Curo Remedies profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Curo Remedies?

Unlock access to Curo Remedies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Curo Remedies?

Unlock and access historical data on people associated with Curo Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Curo Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curo Remedies's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Curo Remedies
Recent Activity within the Organization
  • Director Appointment

    Nilesh Phadnis was appointed as a Director was appointed as a Director on 02 Nov 2012 & has been associated with this company since 13 years 7 months . was recorded as a recent event.

  • Director Appointment

    The activity Prakash Vasant Phadnis was appointed as a Director was appointed as a Director on 02 Nov 2012 & has been associated with this company since 13 years 7 months . was completed.

  • Director Appointment

    The activity Aditi Nilesh Phadnis was appointed as a Director was appointed as a Director on 02 Nov 2012 & has been associated with this company since 13 years 7 months . was completed.

  • Director Appointment

    The activity Sandhya Prakash Phadnis was appointed as a Director was appointed as a Director on 02 Nov 2012 & has been associated with this company since 13 years 7 months . was completed.

  • Company Incorporation

    The activity Curo Remedies Private Limited was registered on 02 Nov 2012 with Roc Mumbai & aged 13 years 7 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Curo Remedies Private Limited?

The CIN of Curo Remedies Private Limited is U36900MH2012PTC237471.

Where is Curo Remedies Private Limited headquartered?

Curo Remedies Private Limited is headquartered at 402, Anand, Kores Towers Pokhran Road No.1, Vartak Nagar, Thane, Maharashtra, 400606.

When was Curo Remedies Private Limited incorporated?

Curo Remedies Private Limited was incorporated on 02 November 2012.

Who are the current directors of Curo Remedies Private Limited?

The current directors of Curo Remedies Private Limited are

What is the primary industry of Curo Remedies Private Limited?

The primary industry of Curo Remedies Private Limited is Manufacturing.

Is Curo Remedies Private Limited a listed company?

Curo Remedies Private Limited is unlisted.

What is the capital structure of Curo Remedies Private Limited?

The authorized capital of Curo Remedies Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available